Imaging of multiple myeloma and related plasma cell dyscrasias.

Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, Bartel T
J Nucl Med. 2012 53 (7): 1091-101

PMID: 22693310 · DOI:10.2967/jnumed.111.098830

Multiple myeloma (MM) is an incurable plasma cell malignancy of the bone marrow. MM has 3 components: diffuse marrow infiltration, focal bone lesions, and soft-tissue (extramedullary) disease. The hallmark biomarker in blood or urine is a monoclonal immunoglobulin, the monoclonal protein. Waldenstrom macroglobulinemia is a similar disease with secretion of IgM. Staging is classically performed with the 1975 Durie-Salmon system, which includes conventional radiographs. Recently updated, the Durie-Salmon Plus staging system includes CT, MRI, and (18)F-FDG PET/CT. The hallmark radiographic lesion of symptomatic MM is a well-demarcated, focal osteolytic bone lesion. The number of focal bone lesions correlates inversely with outcome. Extramedullary disease is typically an aggressive, poorly differentiated form of MM that confers inferior outcome, with median survival of less than 1 y if present at diagnosis. Achievement of a complete response on (18)F-FDG PET before stem-cell transplantation correlates with a superior outcome.

MeSH Terms (13)

Bone and Bones Bone Marrow Neoplasms Bone Neoplasms Humans Magnetic Resonance Imaging Multiple Myeloma Paraproteinemias POEMS Syndrome Positron-Emission Tomography Radiopharmaceuticals Technetium Tc 99m Sestamibi Tomography, X-Ray Computed Whole Body Imaging

Connections (1)

This publication is referenced by other Labnodes entities: